The FTSE 100 index is seen surging by about 5% after President Trump’s tariffs pause last night triggered a relief rally for ...

British stocks tumbled as pharmaceutical shares slumped due to escalating tariffs between the U.S. and China. The FTSE 100 ...

The PA news agency looks at which sectors will be most affected by the plans and what it means for businesses and households.

UK shares declined as global markets anticipated U.S. President Trump's announcement on reciprocal tariffs, sparking trade ...

If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially as antibiotic resistance grows. While it’s currently approved for females ...

The U.S. Food and Drug Administration (FDA) has approved GSK’s Blujepa (gepotidacin), a groundbreaking oral antibiotic for ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

The Food and Drug Administration has approved a new antibiotic that can treat uncomplicated urinary tract infections, or ...

This antibiotic is the first new FDA-approved medication for urinary tract infections in decades, and meets the need for new ...

The US Food and Drug Administration (FDA) has early this week approved GSK's new antibiotic, Blujepa (gepotidacin), for the treatment of uncomplicated urinary tract infections (UTIs) in women aged ...

Varied approaches to remote patient monitoring are in development to close care gaps between patients and rheumatologists, ...